idellecromwell1991.blogspot.com
million. Intelident, a privately held Tampa company that is the parent firm ofseveral dentistry-related enterprises, said in a releasde that the Zila acquisition would create a major dentalp company in the United States. Zila (NASDAQ: headquartered in Scottsdale, Ariz., is a diagnostic company dedicatedf tothe prevention, detection and treatment of oral cancer and periodontalo disease. Intelident’s proposal to the Zila board of directors tops an offer from TolmarHoldings Inc. Zila and a Colorado-based pharmaceutical research, development, manufacturing and commercial operationx company, announced a merger agreement onJune 25.
Intelidenr proposed buying the common stock of Zila for 42 cents a whichis 10.5 percent higher than the 38 cents a share offered by Tolmar. Zila’s common stock closex at 32 cents a share onJune 24. Intelideng also said it would pay 48 cent a sharefor Zila’s preferred stock, compared to the 44 centw a share offered by Tolmar. If the Zila board were to accepty theIntelident proposal, Zila could be required to pay up to $500,0000 in fees to Tolmar under terms of the merger The deal would combine Intelident’s leadership in dental practice management with Zila’s strengthh and experience in the prevention, detection, and treatmeny of oral cancer and periodontal disease, Thomas Intelident chief executive, said in the Intelident is one of Zila’s largestf customers.
Intelident said it expected the transaction would close in September if its proposapis accepted.
Комментариев нет:
Отправить комментарий